Pseudomonas aeruginosa and cystic fibrosis: Correlation between exoenzyme production and patient's clinical state
- 25 September 2003
- journal article
- clinical trial
- Published by Wiley in Pediatric Pulmonology
- Vol. 36 (5) , 405-412
- https://doi.org/10.1002/ppul.10380
Abstract
In this study, we investigated the correlation between the production by Pseudomonas aeruginosa isolates of four exoenzymes (protease, elastase, neuraminidase, and phospholipase C (PLC)) and the clinical state of cystic fibrosis (CF) patients. We studied 212 P. aeruginosa isolates from 22 CF patients chronically infected with this bacterium. Patients were classified into three clinical groups according to a modified Shwachman‐Kulczycki‐Khaw (SKK) scoring system. The production of enzymes by isolates from patients in the three populations was analyzed and compared using four statistical tests: chi‐square, Mann‐Whitney U, principal component analysis, and discriminant analysis. Isolates from patients with excellent or good clinical status (group I, SKK score ≥71) had higher elastase and neuraminidase activities than isolates from the other patients. In contrast, PLC activity, a common characteristic of CF isolates, was higher in isolates from patients with poor or weak clinical status (group III, SKK score ≤55). PLC also appeared to be the best parameter for differentiating between groups I and III. Enzyme production was highly variable in group II isolates (SKK score, 56–70). Our results suggest that P. aeruginosa isolates from patients with good clinical status produce large amounts of neuraminidase, and that PLC production may be involved in the decrease in pulmonary function. Pediatr Pulmonol. 2003; 36:405–412.Keywords
This publication has 39 references indexed in Scilit:
- Immunization with aPseudomonas aeruginosaElastase Peptide Reduces Severity of Experimental Lung Infections Due toP. aeruginosaorBurkholderia cepaciaThe Journal of Infectious Diseases, 2000
- Enzyme polymorphism in Pseudomonas aeruginosa strains recovered from cystic fibrosis patients in FranceMicrobiology, 1999
- The role ofPseudomonas aeruginosaelastase as a potent inflammatory factor in a rat air pouch inflammation modelFEMS Immunology & Medical Microbiology, 1999
- Role of Haemolytic and Non-Haemolytic Phospholipase C from Pseudomonas Aeruginosa in Interleukin-8 release from Human MonocytesJournal of Medical Microbiology, 1997
- Bacterial phospholipases and their role in virulenceTrends in Microbiology, 1997
- Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface.Proceedings of the National Academy of Sciences, 1995
- Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells.Journal of Clinical Investigation, 1993
- Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.Pediatric Pulmonology, 1993
- Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression.Journal of Clinical Investigation, 1992
- The Effect of Piliation and Exoproduct Expression on the Adherence of Pseudomonas aeruginosa to Respiratory Epithelial MonolayersThe Journal of Infectious Diseases, 1990